Yazar "Ersoy B." seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Yayın
    Combination of liposuction with arthroscopic cartilage shaver for the treatment of gynecomastia [Jinekomasti tedavisinde 'liposuction' - artroskopik kikirdak traşlayici kombinasyonu]
    (Turkish Society of Plastic Reconstructive, and Aesthetic Surgery, 2014) Ersoy B.; Aköz T.
    Introduction: Surgical intervention is the most effective treatment modality for adult male patients with longstanding gynecomastia. Various surgical techniques for the correction of gynecomastia were described in the literature. This study was designed to introduce the combination of conventional liposuction with arthroscopic cartilage shaver for the correction of gynecomastia and to evaluate the cosmetic results following surgery. Materials and Methods: Thirteen consecutive patients with a mean age of 27.6 years (range 19-43 years) underwent a combined approach that included liposuction and arthroscopic cartilage shaver. A comparison of the combination modality with other surgical alternatives and the analysis of the end-results were performed. Results: The combination modality was performed in 13 patients, all diagnosed with bilateral gynecomastia. The average volume of aspirated breast tissue was measured as 348 cc. Follow-up periods ranged in duration from 7 to 13 months (on average 10.6 months). Apart from a case with postoperative unilateral hematoma formation no other complication was encountered. One of the patients underwent reoperation because of under-resection. All of the patients had aesthetically pleasant results. Conclusion: Although gynecomastia is a benign condition it nevertheless is able to give rise to serious emotional disturbances; thus gynecomastia constitutes one of the most prevalent reasons for cosmetic surgical interventions. The combination treatment using liposuction and an arthroscopic cartilage shaver in selected cases diagnosed with stage IIa/IIb gynecomastia is an effective treatment alternative for gynecomastia with minimal scar formation.
  • Küçük Resim Yok
    Yayın
    Patients with toxic epidermal necrolysis in intensive care unit of Regional Burn Center [Bölge Yanik Merkezi· yogun bakim üni·tesi·'nde toksi·k epi·dermal nekroli·zi·s'li· hastalar]
    (Anestezi Dergisi, 2014) Kuzucuoglu T.; Saracoglu A.; Yakupoglu S.; Erhan T.; Ersoy B.; Demirhan R.
    Objective: Toxic epidermal necrolysis (TEN) is a potentially life-threatening rare disorder, resulting in possible sepsis and death. The aim of this study is to determine the mortality rate, associated comorbidities, the clinical and epidemiological characteristics of 12 TEN patients hospitalized in our burn unit. Method: Twelve patients diagnosed with TEN and admitted to the burn intensive care unit were included in the study. Age, gender, medication, percentage and depth of skin burn damage, APACHE II scores, surgical interventions, hospitalization time, the duration of mechanical ventilation, complications, mortality and morbidity rates of patients were documented in a retrospective manner. The Scorten Scale was utilized to determine the mortality rate of the patients. Results: Mean age was 35±5.7 years. The ratio of males to females was 5:7 and the average APACHE II score was 15.4±3.2. Epidermal detachment was greater than 75% of the body surface area with a mean hospitalization time of 17±1.2 days. One patient had a history of paracetamol and etodolac, 3 had phenytoin medication. TEN symptoms were seen as a result of anti-tuberculosis treatment in another patient and appeared in four patients after treatment with sultamicilin. Other patients had an unknown etiology. Mean duration of mechanical ventilation support was 3.2±0.7 days. The mortality rate was 16.6% (2/12). Conclusion: Due to the high risk of mortality, patients with TEN may require different approaches and management strategies. We concluded that early identification and interception of the responsible drug and the provision of a specialized supportive care in a burn unit may reduce the mortality rate for toxic epidermal necrolysis.